Company intelligence / Profile preview

Conversio Health

San Luis Obispo, California, United States

Ownership: Private
Development stage: Other

Overview

Conversio Health delivers value-based care and digital management programs for chronic respiratory diseases (COPD, asthma), including custom medication delivery, digital patient monitoring via smart devices, and a virtual pulmonary rehab/self-management platform, resulting in improved medication adherence and reduced hospitalizations (clinical results cited on their marketing website but no peer-reviewed trial data found)

Therapeutic areas: Pulmonology
Modalities: Small moleculeDeviceNon-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

NRx Pharmaceuticals / HOPE Therapeutics (distribution agreement for IV ketamine)Nephron Pharmaceuticals (manufacturing, distribution)

Beyond the preview

Go deeper on Conversio Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conversio Health.

Explore the full profile